Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Antlia Bioscience, Inc. logo — Turning promising peptides into groundbreaking therapeutics...

Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases

Founded 2021 United States Encinitas, United States 4 employees Biotechnology, Health Care

General Information

Company Name Antlia Bioscience, Inc.
Founded Year 2021
Location United States Encinitas, United States
Employees 4
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Antlia Bioscience, Inc.. To contact Antlia Bioscience, Inc., visit antliabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Antlia Bioscience, Inc. compare?

A PDF of Antlia Bioscience, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Antlia Bioscience, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Antlia Bioscience, Inc.

Antlia Bioscience, Inc. is a biotechnology startup founded in 2020 with a mission to develop revolutionary therapeutics for chronic diseases. Utilizing its proprietary chemistry platform, PASylation®, the company is focused on engineering long-acting peptides with refined pharmacologic and pharmacokinetic properties. This approach allows for the creation of promising treatments for a range of chronic illnesses. The company's dedication to making a profound impact in the treatment of cardiovascular and pulmonary diseases is reflected in its slogan, "Turning promising peptides into groundbreaking therapeutics for chronic diseases." Antlia Bioscience's commitment is underpinned by a team of devoted scientists and advisors, as well as collaborative partnerships with esteemed professionals who share the vision of bringing life-changing therapies to the market. As of now, there is no publicly available information regarding the company's latest investment or the involved investors. With its stronghold in the United States, Antlia Bioscience is poised to become a notable player in the biotechnology and healthcare industries.

Business keywords: therapeutics, peptides, chronic diseases, PASylation®, pharmacokinetics, cardiovascular diseases, pulmonary diseases, metabolic diseases, drug development, science, innovation, pharmaceuticals

No funding data available for Antlia Bioscience, Inc. yet.

Antlia Bioscience, Inc. Alternatives & Competitors

View All Alternatives
Antlia Bioscience, Inc. vs
Concortis Biosystems Corp
Concortis Biosystems Corp United States

Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduced side-ef...

5 employees
Biotechnology, Health Care
Antlia Bioscience, Inc. vs
Amira Pharmaceuticals
Amira Pharmaceuticals

Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early...

Series B
15 employees
Biotechnology, Health Care
Antlia Bioscience, Inc. vs
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. United States

We have the next generation in polymer therapeutics. Go to www.serinatherapeutics.com and explore ou...

Grant
15 employees
Biopharma, Biotechnology
Also compare with: Antlia Bioscience, Inc. vs Structure Therapeutics Structure Therapeutics View all alternatives

FAQ About Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases
Antlia Bioscience, Inc. was founded in 2021.
Antlia Bioscience, Inc. is headquartered in Encinitas, United States.
Antlia Bioscience, Inc. operates in Biotechnology and Health Care. Its work centres on therapeutics, peptides, chronic diseases and PASylation®.
Antlia Bioscience, Inc. has approximately 4 employees.
Top alternatives and competitors to Antlia Bioscience, Inc. include Concortis Biosystems Corp, Amira Pharmaceuticals, Serina Therapeutics, Inc., Lumobiotics GmbH, Structure Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antlia Bioscience, Inc. and Concortis Biosystems Corp are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Antlia Bioscience, Inc., https://bouncewatch.com/company/antlia-bioscience-inc, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes